Lupin Pharmaceuticals, INC.

Generic pharmaceutical manufacturer

Based in MD

🤖

AI Overview

With $200K in lobbying spend across 9 quarterly filings, Lupin Pharmaceuticals, INC is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2019 to 2020.

$200K
Total Spend
2
Years Active
1
Firms Hired
1
Lobbyists Deployed
4
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2019$80K
2020$120K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, Defense, Trade

  • electronic drug labeling, drug take back program and USPTO inter partes review procedure.
  • President's Budget For A Better America (FY20202) relating to the Department of Health and Human Services generic drug exclusivity proposal.
  • H.R. 938-The Blocking Act; H.R. 1499-Protecting Consumer Access to Generic Drugs Act of 2019.
  • H.R. 938-The Blocking Act; H.R. 987 - Strengthening Health Care and Lowering Prescription Drug Costs;S. 1895-Lower Health Care Costs Ac.
  • H.R. 938-The Blocking Act; H.R. 987-Strengthening Health Care and Lowering Prescription Drug Costs; S. 1895-Lower Health Care Costs Ac (Sec.205).

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.